Pfizer's Lyrica proves positive for fibromyalgia; Keddem garners $15M for small molecule modulators; Can a Tibetan mushroom treat asthma?;

Conversations on Twitter :

Did financial conflicts of interest around GSK's Advair boost sales in spite of safety concerns?
Celsion's ongoing Phase III liver cancer study sparks investor analysis: how many months of progression free survival can we expect for control and treatment?

 @FierceBiotech: From FierceBiotechIT.com: Cmed expanding in North Carolina as CRO-tech combos take off. Story | Follow @FierceBiotech

 @JohnCFierce: SR One, etc., provide $37.5M round for Applied Genetic Technologies. Working on gene therapies. News | Follow @JohnCFierce

 @RyanMFierce: Cmed expanding in North Carolina as CRO-tech combos take off. Report | Follow @RyanMFierce

> Pfizer ($PFE) says that a Phase III study for Lyrica produced promising evidence of efficacy against fibromyalgia. The condition afflicts some 5 million people in the U.S. Release

> The Baltimore Sun provides an upbeat assessment of MedImmune, noting a big increase in pipeline projects in the years since AstraZeneca ($AZN) bought out the company for $15 billion. Report

> Compugen subsidiary Keddem Bioscience has raised $15 million to back its work on small molecule modulators. Story

Pharma News

@FiercePharma: Pfizer CEO Ian Read ordered to testify in Chantix case. More | Follow @FiercePharma

> Novo Norkdisk, largest Nordic company, shoots for top drugmaker. Report

> Calpers, others, battle Pfizer separately on Bextra shareholder claims. News

> Illumina gets dose of its own medicine, spurned by Complete Gemomics. Item

Medical Device News

 @FierceMedDev: Wright Medical plans to merge with BioMimetic in a $380M deal: orthopedics + regenerative medicine = the future. More | Follow @FierceMedDev

 @MarkHFierce: St. Jude gained a CE mark for its new transcatheter aortic heart valve/transfemoral delivery system. Watch out, Sapien? News | Follow @MarkHFierce

 @DamianFierce: Big week for CRO Chiromics, signing deals with GSK and Bristol-Myers. Story | Follow @DamianFierce

> GE Healthcare slashes jobs in Vermont. Item

> Wright to grab BioMimetic in $190 million-plus agreement. Story

> HeartSine hit with Class I over defibrillator recall. News

> St. Jude Medical wins CE mark for TAVI tech. Article

Biotech IT News

> Merck backs Remedy Informatics with $6M investment. Report

> Roche engages patient groups in social media effort. Article

> Johnson & Johnson, Merck and Eli Lilly to rip red tape from clinical trials. Story

CRO News

> PPD gets high-tech for adaptive trials. Item

> Big Pharma supergroup plots clinical trial site database. Story

> Chiromics inks discovery deals with Bristol-Myers, GSK. Article

> Aptuit extends GSK partnership at Italian site. More

> WuXi ticks up income after strong Q3. Report